Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly.
Douglas E. Paull, MD, MS and Paul N. Uhlig, MD, MPA
Risk managers can help patient-subjects and clinician-researchers make informed novel device implantation decisions in the absence of preclinical trial data.
AMA J Ethics. 2020;22(11):E911-918. doi:
10.1001/amajethics.2020.911.
A physician describes how patients are selected for gastric bypass surgery in his practice and the lifelong relationship he commits to with his surgical patients.
Patients for gastric bypass surgery should be carefully selected on the basis of several objective factors, and those chosen should be treated and monitored by specialized teams to optimize outcomes.